Impact of a Raltegravir-based Regimen on Early Mortality of Severely Immunocompromised AIDS Patients

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified April 2013 by Fundação Bahiana de Infectologia
Sponsor:
Information provided by (Responsible Party):
Carlos Brites, Fundação Bahiana de Infectologia
ClinicalTrials.gov Identifier:
NCT01837277
First received: April 18, 2013
Last updated: April 22, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)